Call for Review of the African Antibiotic Treatment Guidelines for Common Bacterial Infections and Syndromes

  • Version
  • Download 41514
  • File Size 3.34 MB
  • File Count 6
  • Create Date 8 March 2021
  • Last Updated 15 March 2021

Call for Review of the African Antibiotic Treatment Guidelines for Common Bacterial Infections and Syndromes

Instructions for External Review:

The Africa Centres for Disease Control and Prevention (Africa CDC) in collaboration with the Center for Disease Dynamics, Economics & Policy (CDDEP) are developing African Antibiotic Treatment Guidelines for Common Bacterial Infections and Syndromes (First Edition) for publication in 2021. The purpose of these guidelines is to provide healthcare workers across the African continent with expert recommendations for antimicrobial selection, dosage, and duration of treatment for common bacterial infections and syndromes among pediatric and adult patient populations and to promote the appropriate use of antimicrobials to mitigate the emergence and spread of AMR pathogens. The guidelines were based on a review of existing national standard or clinical treatment guidelines, available AMR data, and clinical expertise from an international group of physicians, pharmacists, and other clinicians involved in the treatment of infectious diseases. The treatment recommendations are intended to complement existing national and international clinical treatment guidelines, where available, and to provide a template for local adaption in their absence. The guidelines are intended for use by clinicians, nurses, pharmacists, and other personnel involved in the treatment of infectious diseases or dispensing of antimicrobials in Africa.

This is a call for relevant experts to serve as members of the External Review Group. The purpose of the external review is to ensure that the proposed guidance is appropriate, feasible, and accessible to healthcare workers and other relevant guideline users in Africa.

The External Review Group will be tasked with reviewing the African Antibiotic Treatment Guidelines for Common Bacterial Infections and Syndromes for adult and pediatric patient populations and providing feedback on clinical content including on the availability of suggested antimicrobial selection, dosage, and treatment duration and on the clinical case definitions, principles of stewardship, and other clinical notes that accompany each treatment recommendation. The following guiding questions can serve as an outline for external reviewers for each infection/clinical syndrome for which treatment recommendations are provided:

  1. Does the clinical definition accurately capture the major signs, symptoms, and causative agents of the infection/clinical syndrome?
  2. Are the recommended antimicrobial agents widely available in your facility/country? If no, is there an alternative antimicrobial you would recommend for treatment?
  3. Are the antimicrobial agent formulations widely available in your facility/country? If no, is there an alternative formulation you would recommend for treatment?
  4. Is the dosage and duration clinically appropriate and feasible?
  5. Are there additional principles of stewardship prescribers should take note of when treating the specified infection/syndrome?

Participants in the External Review Group must be qualified healthcare providers, researchers, laboratory staff, or pharmacists with experience diagnosing infectious diseases and prescribing antimicrobial therapies. Participants must currently or previously have lived and worked in any Africa Union member state. Participants may provide input on either the adult or pediatric guidelines or both according to your expertise and clinical experience.

Documents for external review will be made available through the Africa CDC website in English and French. There will be no maximum number of members for the External Review Group.

To submit your feedback, please download the guidelines in French or English as word documents and make edits and changes using the Track Changes and Comments features. Submit your edited documents as attachments to amrafricacdc@africa-union.org with the following information in the body of the e-mail:

  1. Given name/forename
  2. Surname
  3. Degrees and qualifications
  4. Current positions and affiliations
  5. Current Location of Work (City, Country)

The deadline for input submission will be April 30, 2021.

External reviewers will be acknowledged in the final guidelines publication but we are unable to provide any compensation for this service. Africa CDC will give due consideration to all comments received but will not respond to individual comments directly. All feedback received will be posted publicly on this webpage.

 

 

Attached Files

FileAction
Guidelines for Common Bacterial Infections and Syndromes - ENGDownload
Guidelines for Common Bacterial Infections and Syndromes - FREDownload
External review instructions - ENGDownload
External review instructions - FREDownload
Pediatric guidelines - ENGDownload
Pediatric guidelines - FREDownload

In Africa, the number of COVID-19 cases and affected countries has been increasing steadily. As of 24 April 2020, over 27,000 cases and 1,300 deaths have been reported in 52 countries. Community transmission is now widespread. The epidemic has the potential to result in substantial death and suffering in Africa due to four major factors:

  1. Increased risk of transmission,
  2. Increased risk of infection leading to severe illness,
  3. Increased risk of death from severe illness,
  4. Increased suffering among those who survive the pandemic.

This guidance document addresses how physical distancing (referred to in previous guidance documents as ‘social distancing’) can help slow down transmission.

Download Files
FileAction
Download in Portuguese Download
Download in FrenchDownload
Download in ArabicDownload
Download in EnglishDownload